4 research outputs found

    Synthesis, Characterization and Toxicology Studies of the Copper (Ii) Complex of Sodium Barbitone

    Get PDF
    Complexation of sodium barbitone with Cu(II) has been studied. The complex formed was characterized using physical and spectroscopy studies. In the structural characterized complex, Infrared spectra suggest bidentate coordination of the ligand through one carbonyl oxygen, NaO+ oxygen and two carbonyl oxygen of acetate. Electronic spectra revealed octahedral geometry of the complex. Toxicology study was carried out by investigating the effect of the ligand and its complex on cardial muscle, kidney, liver and lung of Sprague dawly rats. Keywords: Sodium barbitone, metal complex, toxicology study, Sprague dawly rats, Cardial muscl

    Substituents Effect on the Kinetics and Mechanisms of Formation of Copper (II) and Nickel (II) Complexes of Some Î’-Diketones

    Get PDF
    Chelates of β – diketones (R1COCH2COR2) with transition metals have been found to possess a wide range of properties and application, some of which are dependent on the substituents (R1 and R2).  Copper(II) and Nickel(II) complexes of β – diketones in which R1= C6H5 and R2 = C6H5 (dbm), R2 = CH3 (bza) R2 = CF3 (tfpbd) and R1 = C4H3S, R2 = CF3(tta) were synthesised and characterised using UV, IR, elemental analysis and magnetic susceptibility. The probable influence of the substituents on the kinetics and mechanisms of formation of the complexes were investigated with the aid of a Thermostated Schimadu 1800 uv-visible spectrophotometer. The reactions were studied at wavelengths characteristics of each complex. Results show the six coordinate copper(II) and nickel(II) complexes have probable distorted octahedral geometry while the four coordinate Ni(dbm)2 is tetrahedral. The kinetics data suggests an influence of the diketonate substituents on the copper(II) and nickel(II) complexes in solution is in the order C6H5 > CH3 >CF3 > C4H3S and CF3 > C6H5 > CH3 > C4H3S respectively. Solvent influence (k-1) was constant in the range 0.007 – 0.008 for fluorosubstituted complexes and least at 0.004 – 0.005 mol-1s-1 in the alkyl substituted complexes. The steady state approximation gave solvent independent rates k1k2 at 25oC, in the copper(II) complexes, k2 is greater than k1 (k2 > k1) , with k2 constant while in the nickel(II) complexes, the values of k2 was less than k1 and ascribed to rate determining and varies with the nickel(II) - ligand systems studied. Keywords: β-diketones, Copper II and Nickel II Complexes, Substituents effect, Kinetics

    Effect of Test and Treat on clinical outcomes in Nigeria: A national retrospective study.

    No full text
    BackgroundIn Nigeria, results from the pilot of the Test and Treat strategy showed higher loss to follow up (LTFU) among people living with HIV compared to before its implementation. The aim of this evaluation was to assess the effects of antiretroviral therapy (ART) initiation within 14 days on LTFU at 12 months and viral suppression.MethodsWe conducted a retrospective cohort study using routinely collected de-identified patient-level data hosted on the Nigeria National Data Repository from 1,007 facilities. The study population included people living with HIV age ≥15. We used multivariable Cox proportional frailty hazard models to assess time to LTFU comparing ART initiation strategy and multivariable log-binomial regression for viral suppression.ResultsOverall, 26,937 (38.13%) were LTFU at 12 months. Among individuals initiated within 14 days, 38.4% were LTFU by 12 months compared to 35.4% for individuals initiated >14 days (p14 days was not statistically significant.ConclusionLTFU was higher among individuals who were initiated within 14 days compared to greater than 14 days after HIV diagnosis. There was no difference for viral suppression. The provision of early tailored interventions to support newly diagnosed people living may contribute to reducing LTFU

    Trial Evaluating Ambulatory Therapy of Travelers’ Diarrhea (TrEAT TD) Study: A Randomized Controlled Trial Comparing 3 Single-Dose Antibiotic Regimens With Loperamide

    No full text
    corecore